Peroxisome Membrane Protein PEX16 Inhibits Melanogenesis by Inhibiting the Wnt/β‐Catenin Signalling Pathway
Experimental Dermatology · 2026
DOI: 10.1111/exd.70204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2026. Verfasst von Xiaolei Duan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Third Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Melanins, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: High Level Health Talents in Hunan Province, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities of Central South University.
Abstract (Originalsprache)
Pigmented diseases can significantly impact people's quality of life, with melanogenesis playing a key role. In this study, we first analysed the relationship between peroxisomes, peroxisomal biogenesis factor 16 (PEX16), and melanin synthesis using omics data and clinical samples. Our results showed that peroxisome function and PEX16 expression were negatively associated with melanogenesis. Overexpression of PEX16 in the melanin‐producing MNT1 cell line resulted in an increase in peroxisome production and the inhibition of key genes related to melanogenesis, such as microphthalmia‐associated transcription factor (MITF), tyrosinase (TYR), tyrosinase‐related protein 1 (TYRP1), and dopachrome tautomerase (DCT). Consistently, when PEX16 was overexpressed in melanocytes, there was a significant reduction in melanin content. The expression of PEX16 was detected in skin tissues. We found that PEX16 expression was higher in the areas with relatively lower pigmentation and decreased following ultraviolet B (UVB) irradiation. Furthermore, our findings suggest that PEX16 can inhibit melanogenesis by suppressing the Wnt/β‐catenin signalling pathway. In conclusion, PEX16 can inhibit the Wnt/β‐catenin signalling pathway, thereby reducing melanogenesis. Our research provides new insights for the clinical diagnosis and treatment of skin pigmentation disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Third Xiangya Hospital of Central South University, Changsha, China.
- Clinical Research Center, Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
ORCID-Profile: Xiaolei Duan, Chuhan Fu, Ling Jiang, Qinghai Zeng
Förderung
- High Level Health Talents in Hunan Province
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities of Central South University
- Young Elite Scientists Sponsorship Program by CACM
- Fundamental Research Funds for Central Universities of the Central South University
- Natural Science Foundation of Hunan Province
Zitieren
APA
Duan, X., Hu, Y., Fu, C., Chen, J., Huang, J., Dai, X., Zhao, Y., Jiang, L., & Zeng, Q. (2026). Peroxisome Membrane Protein PEX16 Inhibits Melanogenesis by Inhibiting the Wnt/β‐Catenin Signalling Pathway. Experimental Dermatology. https://doi.org/10.1111/exd.70204
Vancouver
Duan X, Hu Y, Fu C, Chen J, Huang J, Dai X, et al. Peroxisome Membrane Protein PEX16 Inhibits Melanogenesis by Inhibiting the Wnt/β‐Catenin Signalling Pathway. Experimental Dermatology. 2026. doi:10.1111/exd.70204
BibTeX
@article{Duan2026,
author = {Duan, Xiaolei and Hu, Yibo and Fu, Chuhan and Chen, Jing and Huang, Jinhua and Dai, Xixia and Zhao, Yuanyuan and Jiang, Ling and Zeng, Qinghai},
title = {Peroxisome Membrane Protein PEX16 Inhibits Melanogenesis by Inhibiting the Wnt/β‐Catenin Signalling Pathway},
journal = {Experimental Dermatology},
year = {2026},
doi = {10.1111/exd.70204}
}
EUVIMED